期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

乳腺癌新辅助内分泌治疗进展 被引量：6

下载PDF
导出
摘要 应用PubMed、HighWire期刊全文数据库检索系统,以乳腺癌、新辅助内分泌治疗为关键词,检索2003～2013年的相关文献.通过回顾文献探讨乳腺癌新辅助内分泌治疗研究中的问题及未来发展趋势.
作者 崔海东 刘坚
机构地区 杭州市第一人民医院乳腺外科
出处 《医学研究杂志》 2014年第12期14-17,共4页 Journal of Medical Research
关键词 乳腺癌 新辅助内分泌治疗 进展
分类号 R737 [医药卫生—肿瘤]
  • 相关文献

参考文献16

  • 1Fentiman IS, Christiaens MR, Paridaens R,et al. Treatment of oper- able breast cancer in the elderly: a randomized clinical trial EORTC 10851 comparing tamoxifen alone with modified radical mastectomy [J]. EurJCancer, 2003, 39(3):309-316.
  • 2Ellis MJ, Ma C. Letrozole in the neoadjuvant setting: the P024 trial [J]. Breast Gancer Res Treat, 2007, 105(Suppl 1 ) :33 -43.
  • 3Smith IE, Dowsett M, Ebbs SR, et al. Neoadjuvant treatment of post- menopausal breast cancer with anastrozole, tamoxifen, or both in com- bination: the immediate preoperative anastrozole, tamoxifen, or com- bined with tamoxifen (IMPACT) multicenter double -blind random- ized trial[ J]. J Clin Oncol, 2005, 23 (22) :5108 - 5116.
  • 4Dixon ]M, Renshaw L, Maeaskill EJ,et al. Increase in response rate by prolonged treatment with neoadjuvant letrozole [ J ]. Breast Cancer Res Treat, 2009, 113(1) :145 - 151.
  • 5Ellis MJ,Suman VJ,Hoog J, et al. Randomized phase lI neoadjuvant comparison between letrozole, anastrozole, and exemestane for postm- enopausal women with estrogen receptor - rich Stage 2 to 3 breast cancer: clinical and biomarker outcomes and predictive value of the baseline PAM50 -based intrinsic subtype--ACOSOC, ZIO31[J]. J Clin Oncol , 2011, 29(17) : 2342 -2349.
  • 6Howell AL, Robertson JF, Abram P, et al. Comparison of fulvestrant versus tamoxifen for the treatment of advanced breast cancer in postm- enopausalwomen previously untreated with endocrine therapy: a multi- national, double - blind, randomized trial[ J]. J Clin Oncol,2004, 22(9) :1605 - 1613.
  • 7Howell AL, Robertson JF, Quaresma Albano J, et al. Fulvestrant, formerly ICI 182,780, is as effective as anastrozole in postmenopausal women with advanced breastcancer progressing after prior endocrine treatment [ J ]. J Clin Oncol, 2002, 20 (16) :3396 - 3403.
  • 8Tan PS, Haaland B, Montero AJ, et al. A meta- analysis of anastro- zole in combination with fulvestrant in the first line treatment of hor- mone receptor positive advanced breast cancer[ J]. Breast Cancer Res Treat, 2013, 138(3) : 961 -965.
  • 9Massarweh S, Tham YL, Huang J,et al, A phase I1 neoadjuvant trial of anastrozole, fulvestrant, and gefitinib in patients with newly diag- nosed estrogen receptor positive breast cancer[ J]. Breast Cancer Res Treat, 2011,129(3) : 819 -827.
  • 10Baselga J, Semiglazov V, van Dam P, et al. Phase ][ randomized study of neoadjuvant everolimus plus letrozole compared with placebo plus letrozole in patients with estrogen receptor - positive breast cancer [ J]. J Clin Oncol, 2009, 27 (16) :2630 - 2637.

同被引文献54

  • 1尹子毅,刘晖,李洪利,王丕琳,张铁,宋茂民.乳腺癌组织p53和Ki-67表达及其与新辅助化疗关系的研究[J].中华肿瘤防治杂志,2008,15(9):676-678. 被引量：10
  • 2陈伟财,何劲松,王敏,吴恢升,王先明.老年乳腺癌患者新辅助内分泌治疗的临床应用[J].中国癌症杂志,2011,21(5):359-362. 被引量：23
  • 3王晓红,章爱斌,倪俊,顾凤元.来曲唑在绝经后乳腺癌患者新辅助化疗中的应用价值探讨[J].浙江医学,2006,28(6):502-503. 被引量：9
  • 4Beatson GT. On the treatment of inoper- able cases of carcinoma of the mamma: Suggestions for a new method of treat-ment with illustrative eases[J]. Lancet, 1896, 2: 104-107.
  • 5Valenzuela M, Julian TB. Neoadjuvant hamaonaltherapy[J].Breast, 2008,14(3)979-283.
  • 6Mathew J, Asgeirsson KS, Jackson LR, et al. Neoadjuvant endocrine treatment in primary breast cancer-review of literature[J]. Breast, 2009, 18(6) : 339-344.
  • 7Gunduz N, Fisher B, Saffer EA. Effect of surgical removal on the growth and kine- tics of r esidual tu mor[J]. Cancer Res, 1979,39(10): 3861-3865.
  • 8Chia YH, Ellis M J, Ma CX.Neoadjuvant endocrine therapy in primary breast can- cer: indications and use as a research tool[J]. British Journal of Cancer ,2010,103(6): 759-764.
  • 9Eiermann W, Paepke S, Appfelstaedt J, et al. Preoperative treatment of postmeno- pausal breast cancer patients with letroz- ole: a randomized double-blind multicen- ter study [J]. Ann Oncol, 2001,12 (11): 1527-1532.
  • 10Smith IE, Dowser M, Ebbs SR, et al. Neo- adjuvant treatment ofpostmenopausal bre- ast cancer with anastrozole, tamoxifen, or both in combination: the Immediate Pre- operative Anastrozole, Tamoxifen, or Com- bined with Tamoxifen (IMPACT) multi- center double-blind randomized trial[J]. J Clin Oncol,2005, 23(22): 5108-5116.

引证文献6

二级引证文献11

医学研究杂志
2014年 第12期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部